Craft
Xenikos

Xenikos

Total Funding

$37 M

Xenikos Summary

Company summary

Overview
Xenikos is a clinical-stage biopharmaceutical company. It develops immunotherapies based on the action of toxin-conjugated antibodies for patients suffering immune diseases, or rejection after transplantation.
Type
Private
Status
Active
Founded
2012
HQ
Nijmegen, NL | view all locations
Website
https://www.xenikos.com
Cybersecurity rating
Sectors

Key people

  • Ypke van Oosterhout

    Ypke van Oosterhout, Founder and Chief Executive Officer, Director

  • Douglas E. Williams

    Douglas E. Williams, Chairman of the Board, Non-Executive Director

    • Maarten Frijlink

      Maarten Frijlink, Chief Operating Officer

    • Jake Simson

      Jake Simson, Non-Executive Director

      LocationsView all

      1 location detected

      • Nijmegen, GE HQ

        Netherlands

        Wilhelminasingel 14

      Blogs

      Footer menu